The The WCBP Symposium 2027 advances integration of science, regulations, and digital technologies to enhance global patient-centered care and biotherapeutics development.
Key Topics
Mass Spectrometry fundamentals and industrial applications
Comparability assessments across biologics, vaccines, and cell & gene therapies
Regulatory frameworks and global guidelines (FDA, EMA, PMDA, ICH, WHO)
Advanced analytical technologies for protein characterization and Multi-Attribute Methods
Emerging therapeutic modalities including CRISPR-based gene editing and multispecifics
AI, predictive modeling, and automation in CMC development
Global manufacturing, quality control, and GMP in LMICs
Control and characterization of particulate matter in biologics
Reliance pathways, cloud platforms, and collaborative regulatory strategies
Case studies and best practices for comparability and process intensification
Technology transfers, troubleshooting, and scale-up for manufacturing processes
Who should Attend
Industry professionals in biotechnology and pharmaceutical manufacturing
Regulatory affairs specialists and compliance officers
Analytical scientists and laboratory researchers
Quality assurance and control professionals
Clinical development and process development experts
Academic researchers and educators in biotherapeutics and regulatory science
Digitalization, AI, and data management specialists in life sciences
Policy makers and public-private partnership stakeholders
Professionals involved in global patient access and supply chain management
Venue
The Mayflower Hotel, 1127 Connecticut Avenue NW, Washington, District of Columbia, United States
